Table 2 The influence of various influencing factors on the prevalence of ARLD

Race

46

4,828,061

 Caucasians

3,146,877

68.9% (67.6–70.2)

99.838

 < 0.001

 Africans

484,170

8.9% (8.5–9.4)

99.243

 < 0.001

 Hispanic

814,203

8.6% (7.9–9.4)

99.830

 < 0.001

 Asians

23,931

0.3% (0.1–0.6)

99.905

 < 0.001

Nationality

10

2078

 Minorities^a

1299

61.6% (52.8–70.0)

93.630

 < 0.001

 Han

779

38.4% (30.0–47.2)

93.630

 < 0.001

Severity of disease

147

564,855

 Mild Alcoholic liver disease

9730

2.1% (1.3–3.0)

99.675

 < 0.001

 Alcoholic fatty liver disease

12,566

19.1% (17.0–21.4)

99.695

 < 0.001

 Alcoholic hepatitis

35,819

16.4% (13.4–19.6)

99.870

 < 0.001

 Alcoholic cirrhosis

348,848

32.9% (27.3–38.7)

99.939

 < 0.001

 Other

157,892

6.0% (3.0–9.8)

99.955

 < 0.001

By complication

119

3,527,134

 SBP

97,135

0.2% (0–0.5)

99.918

0.020

 Hepatorenal syndrome

193,512

0.7% (0.4–1.1)

99.820

 < 0.001

 Infection

119,448

2.4% (1.6–3.3)

99.935

 < 0.001

 Gastrointestinal haemorrhage

575,413

7.5% (6.0–9.2)

99.951

 < 0.001

 Encephalopathy

1,006,363

10.6% (8.8–12.6)

99.954

 < 0.001

 Ascites

1,465,780

25.1% (20.5–30.0)

99.986

 < 0.001

Duration of alcohol intake(yr)

19

4576

 < 0.001

 5–9(yr)

449

13.0% (9.1–17.5)

94.043

 < 0.001

 10–19(yr)

1187

29.5% (24.9–34.3)

90.974

 < 0.001

 ≥ 20(yr)

2940

54.8% (46.9–62.6)

96.366

 < 0.001

Daily dose of pure alcohol consumed (g/d)

20

4184

146.6 (123.8,169.4)

100

 < 0.001

Smoking

27

106,599

59.5% (55.9–63.1)

98.779

 < 0.001

By viral infection

67

1,473,951

 < 0.001

 HBV

11,712

3.6% (3.0–4.3)

99.637

 < 0.001

 HCV

66,744

5.6% (4.1–7.4)

99.932

 < 0.001

 HBV and/or HCV

92,548

18.7% (16.0–21.5)

99.929

 < 0.001